sublingual vs injectable semaglutide Drops – Doctor Adam What to Know About Semaglutide:

BMO compared the Phase I results for TERN-601 to oral competitors such as Eli Lillys orforglipron, which has achieved 3.9% weight loss in a similar study, and Pfizers danuglipron, which led to 5.2% weight loss

"Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review." Pharmaceuticals , 2025

10.1016/j.jns.2013.12.026 26

You market a treatment by convincing doctors and patients to diagnose the illness that your drug or procedure treats, writes Carl Elliott in his essay Pharmaceutical Propaganda from the book Against Health: How Health Became the New Morality

Approximately 25% of total weight lost on tirzepatide was lean mass (SURMOUNT-1 DXA substudy), and in semaglutide trials, that proportion may reach up to 40% (STEP 1 DXA subset)